Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

FRESENIUS SE : UBS gives a Neutral rating

share with twitter share with LinkedIn share with facebook
06/26/2020 | 07:21am EDT

UBS's research confirms his advice and maintains his neutral opinion on the stock.. The target price remains unchanged at EUR 47.

Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 2.63% 76.6 Delayed Quote.13.13%
FRESENIUS SE & CO. KGAA 1.80% 43.07 Delayed Quote.-15.76%
UBS GROUP AG 0.98% 10.8 Delayed Quote.-12.52%

© MarketScreener with dpa-AFX Analyser 2020
share with twitter share with LinkedIn share with facebook
Latest news on FRESENIUS SE & CO. KGAA
07/31FRESENIUS SE : Credit Suisse remains Neutral
MD
07/31FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Credit Suisse
MD
07/31European Companies Begin Reinstating Guidance After Coronavirus Upheaval
DJ
07/31FRESENIUS SE : Independant Research maintains a Buy rating
MD
07/31FMC FRESENIUS MEDICAL CARE AG & CO K : Raised to Buy by Independant Research
MD
07/31FMC FRESENIUS MEDICAL CARE AG & CO K : Deutsche Bank reiterates its Buy rating
MD
07/31FRESENIUS SE : Deutsche Bank maintains a Buy rating
MD
07/31FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
07/30FRESENIUS MEDICAL CARE : cuts 2020 outlook on pandemic impact
RE
07/30FRESENIUS SE : Barclays reiterates its Neutral rating
MD
More news
Financials
Sales 2020 36 315 M 42 770 M 42 770 M
Net income 2020 1 839 M 2 166 M 2 166 M
Net Debt 2020 23 426 M 27 590 M 27 590 M
P/E ratio 2020 12,9x
Yield 2020 2,13%
Capitalization 23 564 M 27 877 M 27 753 M
EV / Sales 2020 1,29x
EV / Sales 2021 1,14x
Nbr of Employees 302 846
Free-Float 72,1%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 50,80 €
Last Close Price 42,27 €
Spread / Highest target 60,4%
Spread / Average Target 20,2%
Spread / Lowest Target -43,0%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors